Thelin® (sitaxentan): intended withdrawal from the market
2010.12.14
Active substance: sitaxentan
The pharmaceutical company Pfizer has informed the BfArM that it intends to withdraw Thelin® (sitaxentan) from the market.
risk information - full text (available in German only)